Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia

Blood

Volumn 90, Issue 8, 1997, Pages 2962-2968

  Weisdorf, Daniel J ^a   Billett, Amy L ^b   Hannan, Peter ^b   Ritz, Jerome ^b   Sallan, Stephen E ^b   Steinbuch, Michael ^b   Ramsay, Norma K C ^b  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE DEFICIENCY; INFANT; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL;

EID: 0030765384     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.8.2962     Document Type: Article

References (38)

1. Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM: Treatment of acute lymphoblastic leukemia - 30 years' experience at St. Jude Children's Research Hospital. N Engl J Med 329:1289, 1993
2. Linker CA, Levitt LW, O'Donnell M, Forman SJ, Ries CA: Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: A follow-up report. Blood 78:2814, 1991
3. Hoelzer D, Thiel E, Loffler H, Buchner T, Ganser A, Heil G, Koch P, Freund M, Diedrich H, Ruhl H, Maschmeyer G, Lipp T, Nowrousian MR, Burkert M, Gerecke D, Pralle H, Muller U, Lunscken C, Fulle H, Ho AD, Kuchler R, Busch FW, Schneider W, Gorg C, Emmerich B, Braumann D, Vaupel HA, von Paleske A, Bartels H, Neiss A, Messerer D: Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 71:123, 1988
4. Hussein KK, Dahlberg S, Head D, Waddell CC, Dabich L, Weick JK, Morrison F, Saiki JH, Metz E, Rivkin SE, Grever MR, Boldt D, the South Western Oncology Group (SWOG): Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy. Blood 73:57, 1989
5. Henze G, Fengler R, Hartmann R, Kornhuber B, Janka-Schaub G, Niethammer D, Riehm H: Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM Group. Blood 78:1166, 1991
6. Barrett AJ, Horowitz MM, Pollack BH, Zhang M-J, Bortin MM, Buchanan GR, Camitta BM, Ochs J, Graham-Pole J, Rowlings PA, Rimm AA, Klein JP, Shuster JJ, Sobocinski KA, Gale RP: Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in second remission. N Engl J Med 331:1253, 1994
7. Horowitz MM, Messerer D, Hoelzer D, Gale RP, Neiss A, Atkinson K, Barrett AJ, Büchner T, Freund M, Heil G, Hiddemann W, Kolb H-J, Löffler H, Marmont AM, Maschmeyer G, Rimm AA, Rozman C, Sobocinski KA, Speck B, Thiel E, Weisdorf DJ, Zwaan FE, Borton MM: Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Ann Intern Med 115:13, 1991
8. Barrett AJ, Horowitz MM, Gale RP, Biggs JC, Camitta BM, Dicke KA, Gluckman E, Good RA, Herzig RH, Lee MB, Marmont AM, Masaoka T, Ramsay NKC, Rim AA, Speck B, Zwaan FE, Bortin MM: Marrow transplantation for acute lymphoblastic leukemia: Factors affecting relapse and survival. Blood 74:862, 1989
9. Thomas ED, Sanders JE, Flournoy N, Johnson FL, Buckner CD, Clift RA, Fefer A, Goodell BW, Storb R, Weiden PL: Marrow transplantation for patients with acute lymphoblastic leukemia: A long-term follow-up. Blood 62:1139, 1983
10. Weisdorf DJ, Nesbit ME, Ramsay NKC, Woods WG, Goldman A, Kim TH, Hurd DD, McGlave PB, Kersey JH: Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: Prolonged survival associated with acute graft-versus-host-disease. J Clin Oncol 5:1348, 1987
11. Chao NJ, Forman SJ, Schmidt GM, Snyder DS, Amylon MD, Konrad PN, Nademanee AP, O'Donnell MR, Parker PM, Stein AS, Smith E, Wong RM, Hoppe RT, Blume KG: Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission. Blood 8:1923, 1991
12. Weisdorf DJ, Woods WG, Nesbit ME, Uckun F, Dusenbery K, Kim T, Haake R, Thomas W, Kersey JH, Ramsay NKC: Allogeneic bone marrow transplantation for acute lymphoblastic leukemia: Risk factors and clinical outcome. Br J Haematol 86:62, 1994
13. Ritz J, Ramsay NK, Kersey JH: Autologous bone marrow transplantation for acute lymphoblastic leukemia, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. Cambridge, MA, Blackwell Scientific Publications, 1994, p 731
14. Weisdorf DJ: Autologous bone marrow transplantation for acute lymphoblastic leukemia, in Atkinson K (ed): Clinical Bone Marrow Transplantation, Cambridge, UK, Cambridge University Press, 1994, p 117
15. Ramsay NKC, LeBien T, Nesbit M, McGlave P, Weisdorf D, Kenyon P, Hurd D, Goldman A, Kim T, Kersey J: Autologous bone marrow transplant for patients with acute lymphoblastic leukemia in second or subsequent remission: Results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement. Blood 66:508, 1985
16. Simonsson B, Burnett AK, Prentice HG, Hann IH, Brenner MK, Gibson B, Grob JP, Lönnerholm G, Morrison A, Smedmyr B, Todd A, Öberg G, Gilmore M, Campana D, Tötterman Th: Autologous bone marrow transplantation with monoclonal antibody purged marrow for high risk acute lymphoblastic leukemia. Leukemia 3:631, 1989
17. Herve P, Labopin M, Plouvier E, Palut P, Tiberghien P, Gorin NC: Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia - A European survey. Bone Marrow Transplant 8:72, 1991 (suppl)
18. Parsons SK, Castellino SM, Lehmann LE, Eickhoff CE, Tarbell NJ, Sallan SE, Weinstein JH, Billett AL: Relapsed acute lymphoblastic leukemia: Similar outcomes for autologous and allogeneic marrow transplantation in selected children. Bone Marrow Transplant 17:763, 1996
19. Billett AL, Kornmehl E, Tarbell NJ, Weinstein HJ, Gelber RD, Ritz J, Sallan SE: Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia. Blood 81:1651, 1993
20. Uckun FM, Kersey JH, Vallera DA, Ledbetter JA, Weisdorf D, Myers DE, Haake R, Ramsay NKC: Autologous bone marrow transplantation in high-risk transmission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging. Blood 76:1723, 1990
21. Uckun FM, Kersey JH, Haake, R, Weisdorf D, Ramsay NKC: Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxy-cyclophosphamide for ex vivo bone marrow purging. Blood 79:1094, 1992
22. Doney K, Buckner C, Fisher L, Petersen FB, Sanders J, Appelbaum FR, Anasetti C, Badger C, Bensinger W, Deeg HJ, Fefer A, Martin P, Petersdorf E, Schuening F, Singer J, Stewart P, Storb R, Sullivan KM, Witherspoon R, Hansen JA: Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia. Bone Marrow Transplant 12:315, 1993
23. Kernan NA, Bartsch G, Ash RC: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328:593, 1993
24. Beatty PG, Hansen JA, Longton GA, Thomas ED, Sanders JE, Martin PJ, Bearman SI, Anasetti C, Petersdorf EW, Mickelson EM, Pepe MS, Appelbaum FR, Buckner CD, Clift RA, Petersen FB, Stewart PS, Storb RF, Sullivan KM, Tesler MC, Witherspoon RP: Marrow transplantation from HLA-matched URDs for treatment of hematologic malignancies. Transplantation 51:443, 1991
25. Davies SM, Shu XO, Blazar BR, Filipovich AH, Kersey JH, Krivit W, McCullough J, Miller WJ, Ramsay NKC, Segall M, Wagner JE, Weisdorf DJ, McGlave PB: Unrelated donor bone marrow transplantation: Influence of HLA A and B incompatibility on outcome. Blood 86:1636, 1995
26. Bearman SI, Mori M, Beatty PG, Meyer WG, Buckner CD, Petersen FB, Sanders JE, Anasetti C, Martin P, Appelbaum FR, Hansen JA: Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors. Bone Marrow Transplant 13:31, 1994
27. Busca A, Anasetti C, Anderson G, Appelbaum FR, Buckner CD, Doney K, Martin PJ, Petersdorf E, Sanders JE, Hansen JA: Unrelated donor or autologous marrow transplantation for treatment of acute leukemia. Blood 83:3077, 1994
28. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb H-J, Rimm AA, Ringdén L, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM: Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555, 1990
29. Uckun F, Kersey J, Haake R, Weisdorf D, Nesbit M, Ramsay N: Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation of acute lymphoblastic leukemia. N Engl J Med 93:1296, 1993
30. Soiffer RJ, Roy DC, Gonin R, Murray C, Anderson KC, Freedman AS, Rabinowe SN, Robertson MJ, Spector N, Pesek K, Mauch P, Nadler LM, Ritz J: Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia. Bone Marrow Transplant 12:243, 1993
31. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
32. Cox DR: Regression models and life tables (with discussion). J R Stat Soc Series B 34:187, 1972
33. Ciampi A, Chang CM, Hoog S, McKinney S: Recursive partition: A versatile method for exploratory data analysis in biostatistics, in MacNeil B, Umphrey GJ, Norwell MA (eds): Biostatistics. D. Riedel, 1987, p 23
34. Stroncek D, Bartsch G, Perkins HA, Randall BL, Hansen JA, McCullough J: The National Marrow Donor Program. Transfusion 33:567, 1993
35. Ochs L, Shu XO, Miller J, Enright H, Wagner J, Filipovich A, Miller W, Weisdorf D: Late infections following allogeneic bone marrow transplantation: Comparison of incidence in related and unrelated donor transplant recipients. Blood 86:3979, 1995
36. Fay JW, Wingard JR, Antin JH, Collins RH, Pineiro LA, Blazar BR, Saral R, Bierer BE, Przepiorka D, Fitzsimmons WE, Maher RM, Weisdorf DJ: FK506 (tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogeneic bone marrow transplantation. Blood 87:3514, 1996
37. Ash RC, Casper JT, Chitambar CR, Hansen R, Bunin N, Truitt RL, Lawton C, Murray K, Hunter J, Baxter-Lowe LA, Gottschall JL, Oldham K, Anderson T, Camitta B, Menitove J: Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med 322:485, 1990
38. Davies SM, Ramsay NKC, Weisdorf DJ: Feasibility and timing of unrelated donor identification for patients with ALL. Bone Marrow Transplant 17:737, 1996